{"id":30945,"date":"2022-07-15T09:47:29","date_gmt":"2022-07-15T07:47:29","guid":{"rendered":"https:\/\/der-arzneimittelbrief.com\/?p=30945"},"modified":"2022-07-15T13:04:42","modified_gmt":"2022-07-15T11:04:42","slug":"neue-nomenklatur-fuer-therapeutisch-eingesetzte-monoklonale-antikoerper","status":"publish","type":"post","link":"https:\/\/der-arzneimittelbrief.com\/artikel\/2022\/neue-nomenklatur-fuer-therapeutisch-eingesetzte-monoklonale-antikoerper","title":{"rendered":"Neue Nomenklatur f\u00fcr therapeutisch eingesetzte monoklonale Antik\u00f6rper"},"content":{"rendered":"<p>Die Weltgesundheitsorganisation (WHO) vergibt seit 1991 internationale Freinamen f\u00fcr Arzneimittel (englisch: International Nonproprietary Name = INN). Zur Unterscheidung von Arzneimittelklassen werden dabei bestimmte Suffixe verwendet, z.B. &#8211;dipin f\u00fcr Kalziumantagonisten oder &#8211;cillin f\u00fcr Abk\u00f6mmlinge der 6-Aminopenicillans\u00e4ure. Therapeutisch eingesetzte monoklonale Antik\u00f6rper (mAK) sind bislang an dem Suffix &#8211;mab zu erkennen. Der INN-Name von mAK hat drei weitere [&hellip;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Die Weltgesundheitsorganisation (WHO) vergibt seit 1991 internationale Freinamen f\u00fcr Arzneimittel (englisch: International Nonproprietary Name = INN). Zur Unterscheidung von Arzneimittelklassen werden dabei bestimmte Suffixe verwendet, z.B. &#8211;dipin f\u00fcr Kalziumantagonisten oder &#8211;cillin f\u00fcr Abk\u00f6mmlinge der 6-Aminopenicillans\u00e4ure. Therapeutisch eingesetzte monoklonale Antik\u00f6rper (mAK) sind bislang an dem Suffix &#8211;mab zu erkennen. Der INN-Name von mAK hat drei weitere [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[5705,5704,5703,5706,5707],"class_list":["post-30945","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-antikoerper","tag-inn","tag-international-nonproprietary-name","tag-monoklonale-antikoerper","tag-nomenklatur"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/30945","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=30945"}],"version-history":[{"count":0,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/30945\/revisions"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=30945"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=30945"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=30945"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}